Your browser doesn't support javascript.
loading
Preclinical evidence for an effective therapeutic activity of FL118, a novel survivin inhibitor, in patients with relapsed/refractory multiple myeloma.
Holthof, Lisa C; van der Horst, Hilma J; van Hal-van Veen, Susan E; Ruiter, Ruud W J; Li, Fengzhi; Buijze, Marijke; Andersen, Morten N; Yuan, Huipin; de Bruijn, Joost; van de Donk, Niels W C J; Lokhorst, Henk M; Zweegman, Sonja; Groen, Richard W J; Mutis, Tuna.
Affiliation
  • Holthof LC; Department of Hematology, Amsterdam UMC, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, the Netherlands.
  • van der Horst HJ; Department of Hematology, Amsterdam UMC, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, the Netherlands.
  • van Hal-van Veen SE; Department of Hematology, Amsterdam UMC, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, the Netherlands.
  • Ruiter RWJ; Department of Hematology, Amsterdam UMC, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, the Netherlands.
  • Li F; Department of Pharmacology & Therapeutics, Roswell Park Comprehensive Cancer Center, New York, NJ USA.
  • Buijze M; Department of Otolaryngology-Head and Neck Surgery, Amsterdam UMC, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, the Netherlands.
  • Andersen MN; Department of Clinical Biochemistry, Aarhus University Hospital, Aarhus, Denmark.
  • Yuan H; Department of Biomedicine, Aarhus University, Aarhus, Denmark.
  • de Bruijn J; Department of Hematology, Aarhus University Hospital, Aarhus, Denmark.
  • van de Donk NWCJ; Kuros Biosciences BV, Bilthoven, the Netherlands.
  • Lokhorst HM; Kuros Biosciences BV, Bilthoven, the Netherlands.
  • Zweegman S; The School of Engineering and Materials Science, Queen Mary University of London, London, UK.
  • Groen RWJ; Department of Hematology, Amsterdam UMC, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, the Netherlands.
  • Mutis T; Department of Hematology, Amsterdam UMC, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, the Netherlands.
Haematologica ; 105(2): e80-e83, 2020.
Article in En | MEDLINE | ID: mdl-31123033
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Survivin / Indolizines / Multiple Myeloma Limits: Humans Language: En Journal: Haematologica Year: 2020 Document type: Article Affiliation country: Netherlands Country of publication: Italy
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Survivin / Indolizines / Multiple Myeloma Limits: Humans Language: En Journal: Haematologica Year: 2020 Document type: Article Affiliation country: Netherlands Country of publication: Italy